Teva, AstraZeneca Say Court Rulings Kill Nexium Delay Suit
Drugmakers Teva Pharmaceutical Industries Ltd. and AstraZeneca PLC on Monday asked a Massachusetts federal judge to toss claims that Teva purposely delayed marketing a generic version of Nexium by two years,...To view the full article, register now.
Already a subscriber? Click here to view full article